DOTA: A Key Chelator for Advanced MRI Contrast Agents and Radiopharmaceuticals
Unlocking precise medical imaging and targeted therapies with a leading macrocyclic chelator.
Get a Quote & SampleProduct Core Value
Tetraazacyclododecane Tetraacetic Acid
Tetraazacyclododecane Tetraacetic Acid (DOTA) is a paramount chelating agent crucial for developing advanced medical diagnostic and therapeutic agents. Its exceptional stability and ability to form robust complexes with various metal ions, particularly Gadolinium for MRI and radioisotopes for therapy, make it indispensable in modern medicine.
- The remarkable stability of Gd-DOTA complexes has established them as the gold standard for reliable vascular imaging in MRI, a key aspect when considering DOTA chelator MRI contrast agents.
- Its structural versatility allows for functionalization, enabling the creation of targeted MRI contrast agents for specific tissues and organs, enhancing diagnostic precision.
- DOTA is pivotal in the development of therapeutic radiopharmaceuticals, facilitating the targeted delivery of radioactive isotopes for cancer treatment, showcasing its role in macrocyclic chemistry in medicine.
- The 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid synthesis pathways are continually optimized to ensure high purity and yield, supporting the growing demand for these critical medical compounds.
Advantages Offered by the Product
Unparalleled Stability
The inherent thermodynamic stability of DOTA makes it superior to linear chelators like DTPA, ensuring that metal ions remain safely bound even under physiological conditions, a critical factor for Gd-DOTA stability.
Versatile Functionalization
The macrocyclic structure of DOTA provides multiple sites for chemical modification, allowing for the attachment of targeting vectors to create personalized targeted MRI contrast agents and therapeutic delivery systems.
Broad Application Spectrum
From foundational blood-pool imaging to sophisticated targeted therapies, DOTA's applications span a wide range, making it a cornerstone in both diagnostic imaging and nuclear medicine, crucial for therapeutic radiopharmaceuticals.
Key Applications
MRI Contrast Agents
DOTA chelates with paramagnetic metal ions like Gadolinium to create highly stable contrast agents for Magnetic Resonance Imaging, enhancing the visualization of anatomical structures and pathologies.
Radiopharmaceuticals
Its ability to chelate radioactive isotopes makes DOTA essential for developing diagnostic and therapeutic radiopharmaceuticals used in cancer detection and treatment.
Bioconjugation
DOTA can be conjugated to biomolecules such as peptides and antibodies, enabling targeted delivery of imaging or therapeutic agents to specific cells or tissues.
Research and Development
Ongoing research utilizes DOTA in developing novel metal-containing agents, contributing to advancements in personalized medicine and targeted drug delivery systems.